The use of systemic anticancer chemotherapy is intrinsically limited by its toxicity. Whether
dealing with small molecules or biopharmaceuticals, after systemic administration, small …

Transdermal drug delivery refers to a means of delivering drugs through the surface of the
skin for local or systemic treatment. The drug functions after absorption through the skin into …

Breast cancer incidence has increased in recent decades. In the present study, an optimum
formulation of chitosan (CS)-adorned niosome-based nanocarriers for co-delivery of …

BODIPYs are photosensitizers activatable by light to generate highly reactive singlet oxygen
(1 O 2) from molecular oxygen, leading to tissue damage in the photoirradiated region …

Numerous human disorders can benefit from targeted, intravenous (IV) drug delivery.
Polymeric nanoparticles have been designed to undergo systemic circulation and deliver …

The incidence rate of breast cancer in women is high, and this has caused a significant
health problem for society and public health providers.(p1) The epidemiological data …

Chitosan-functionalized magnetite/poly (ε-caprolactone) nanoparticles were formulated by
interfacial polymer disposition plus coacervation, and loaded with gemcitabine. That …

Purpose The use of nanocarriers to improve the delivery and efficacy of antimetastatic
agents is less explored when compared to cytotoxic agents. This study reports the …

Niosomes are biocompatible nanocarriers that could be used for designing drug delivery
systems. In this work, we report the synthesis, characterization and antibacterial/antibiofilm …

Drug delivery systems (DDS) can be designed to enrich the pharmacological and
therapeutic properties of several drugs. Many of the initial obstacles that impeded the clinical …